# Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer

> **NCT00804154** · PHASE1 · RECRUITING · sponsor: **National Institute of Dental and Craniofacial Research (NIDCR)** · enrollment: 45 (estimated)

## Conditions studied

- Intractable Pain
- Palliative Care

## Interventions

- **DRUG:** Intrathecal Resiniferatoxin

## Key facts

- **NCT ID:** NCT00804154
- **Lead sponsor:** National Institute of Dental and Craniofacial Research (NIDCR)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2009-08-14
- **Primary completion:** 2027-02-07
- **Final completion:** 2027-02-07
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2026-05-01

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00804154

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00804154, "Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00804154. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*